☰

Jonas Eberhard, MD, PhD - Publications

Affiliations: 
Department for Psychosis studies Institute of Psychiatry, KCL, London, England, United Kingdom 
Area:
Psychosis
Tree Info Grants Similar researchers PubMed Report error

33 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Iliachenko EK, Ragazan DC, Eberhard J, Berge J. Suicide mortality after discharge from inpatient care for bipolar disorder: A 14-year Swedish national registry study. Journal of Psychiatric Research. 127: 20-27. PMID 32450359 DOI: 10.1016/J.Jpsychires.2020.05.008  0.334
2020 El Mrayyan N, Bökberg C, Eberhard J, Ahlström G. Healthcare utilisation patterns among older people with intellectual disability and with affective and anxiety diagnoses in comparison with the general population. Aging & Mental Health. 1-10. PMID 32208744 DOI: 10.1080/13607863.2020.1742657  0.302
2019 Axmon A, El Mrayyan N, Eberhard J, Ahlström G. Pharmacotherapy for mood and anxiety disorders in older people with intellectual disability in comparison with the general population. Bmc Psychiatry. 19: 238. PMID 31370823 DOI: 10.1186/S12888-019-2191-7  0.321
2019 Ragazan DC, Eberhard J, Ösby U, Berge J. Gender influence on the bipolar disorder inpatient length of stay in Sweden, 2005-2014: A register-based study. Journal of Affective Disorders. 256: 183-191. PMID 31177046 DOI: 10.1016/J.Jad.2019.05.052  0.592
2019 Westman J, Eberhard J, Gaughran FP, Lundin L, Stenmark R, Edman G, Eriksson SV, Jedenius E, Rydell P, Overgaard K, Abrams D, Greenwood KE, Smith S, Ismail K, Murray R, et al. Outcome of a psychosocial health promotion intervention aimed at improving physical health and reducing alcohol use in patients with schizophrenia and psychotic disorders (MINT). Schizophrenia Research. PMID 30979666 DOI: 10.1016/J.Schres.2019.03.026  0.654
2019 Eriksson SVEN, Eberhard J, Osby U, Westman J, Forslund L, Wallen J. P2547Statin and glucose-lowering treatment in individuals with and without schizophrenia European Heart Journal. 40. DOI: 10.1093/Eurheartj/Ehz748.0875  0.454
2017 Gaughran F, Stahl D, Ismail K, Greenwood K, Atakan Z, Gardner-Sood P, Stubbs B, Hopkins D, Patel A, Lally J, Lowe P, Arbuthnot M, Orr D, Corlett S, Eberhard J, et al. Randomised control trial of the effectiveness of an integrated psychosocial health promotion intervention aimed at improving health and reducing substance use in established psychosis (IMPaCT). Bmc Psychiatry. 17: 413. PMID 29284438 DOI: 10.1186/S12888-017-1571-0  0.404
2017 Suppes T, Eberhard J, Lemming O, Young AH, McIntyre RS. Anxiety, irritability, and agitation as indicators of bipolar mania with depressive symptoms: a post hoc analysis of two clinical trials. International Journal of Bipolar Disorders. 5: 36. PMID 29105003 DOI: 10.1186/S40345-017-0103-7  0.337
2017 Theleritis C, Bonaccorso S, Habib N, Stahl D, Gaughran F, Vitoratou S, Atakan Z, Kolliakou A, Gardner Sood P, Dazzan P, Marques TR, McGuire P, Greenwood K, Eberhard J, Breedvelt J, et al. Sexual dysfunction and central obesity in patients with first episode psychosis. European Psychiatry : the Journal of the Association of European Psychiatrists. 42: 1-7. PMID 28199868 DOI: 10.1016/J.Eurpsy.2016.11.008  0.381
2016 Eberhard J, Weiller E. Suicidality and symptoms of anxiety, irritability, and agitation in patients experiencing manic episodes with depressive symptoms: a naturalistic study. Neuropsychiatric Disease and Treatment. 12: 2265-71. PMID 27621637 DOI: 10.2147/Ndt.S111094  0.364
2016 Mortensen GL, De J, Holme M, Neve T, Torell PG, Eberhard J. Social Aspects of the Quality of Life of Persons Suffering from Schizophrenia Open Journal of Psychiatry. 6: 50-60. DOI: 10.4236/Ojpsych.2016.61005  0.387
2015 Young AH, Eberhard J. Evaluating depressive symptoms in mania: a naturalistic study of patients with bipolar disorder. Neuropsychiatric Disease and Treatment. 11: 1137-43. PMID 25995638 DOI: 10.2147/Ndt.S82532  0.359
2015 Lee Mortensen G, Vinberg M, Lee Mortensen S, Balslev Jørgensen M, Eberhard J. Bipolar patients' quality of life in mixed States: a preliminary qualitative study. Psychopathology. 48: 192-201. PMID 25895658 DOI: 10.1159/000381479  0.323
2014 Brain C, Sameby B, Allerby K, Lindström E, Eberhard J, Burns T, Waern M. Twelve months of electronic monitoring (MEMS®) in the Swedish COAST-study: a comparison of methods for the measurement of adherence in schizophrenia. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 24: 215-22. PMID 24359935 DOI: 10.1016/J.Euroneuro.2013.11.013  0.339
2014 Brain C, Allerby K, Sameby B, Quinlan P, Joas E, Karilampi U, Lindström E, Eberhard J, Burns T, Waern M. Poster #T29 HOW TO PREDICT AND MEASURE MEDICATION ADHERENCE IN SCHIZOPHRENIA: TWELVE MONTHS OF ELECTRONIC MONITORING (MEMS®) IN THE SWEDISH COAST-STUDY Schizophrenia Research. 153. DOI: 10.1016/S0920-9964(14)70846-1  0.336
2013 Brain C, Allerby K, Sameby B, Quinlan P, Joas E, Karilampi U, Lindström E, Eberhard J, Burns T, Waern M. Drug attitude and other predictors of medication adherence in schizophrenia: 12 months of electronic monitoring (MEMS(®)) in the Swedish COAST-study. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 23: 1754-62. PMID 24091164 DOI: 10.1016/J.Euroneuro.2013.09.001  0.378
2013 Young AH, Eberhard J, Weiller E. Efficacy of asenapine in manic episodes with depressive symptoms: a review of post-hoc analyses International Journal of Psychiatry in Clinical Practice. 17: 36-37. DOI: 10.3109/13651501.2013.851555  0.332
2011 Lindström E, Eberhard J, Fors BM, Hansen K, Sapin C. A pharmacoeconomic analysis of sertindole in the treatment of schizophrenia in Sweden. Nordic Journal of Psychiatry. 65: 403-13. PMID 21770821 DOI: 10.3109/08039488.2011.590603  0.412
2009 Eberhard J, Levander S, Lindström E. Remission in schizophrenia: analysis in a naturalistic setting. Comprehensive Psychiatry. 50: 200-8. PMID 19374962 DOI: 10.1016/J.Comppsych.2008.08.010  0.662
2008 Lublin H, Eberhard J. Foreword. Content versus delivery: challenges and options in the treatment of schizophrenia. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 18: v-vi. PMID 18495441 DOI: 10.1016/J.Euroneuro.2008.04.001  0.38
2008 Tamminga CA, Eberhard J, Tanghøj P. TOWARDS PERSONALIZED MEDICATION IN SCHIZOPHRENIA: HYPOTHESIS-GENERATING FINDINGS ON PREDICTORS OF TREATMENT RESPONSE AND WITHDRAWAL Schizophrenia Research. 102: 278. DOI: 10.1016/S0920-9964(08)70836-3  0.395
2007 Eberhard J, Tamminga C, Tanghoj P. Factors predicting patient withdrawal from long-term treatment of schizophrenia Nervenarzt. 78: 70-70. PMID 17992556 DOI: 10.1007/S00115-007-2382-1  0.387
2007 Lindström E, Eberhard J, Neovius M, Levander S. Costs of schizophrenia during 5 years. Acta Psychiatrica Scandinavica. Supplementum. 33-40. PMID 17953524 DOI: 10.1111/J.1600-0447.2007.01086.X  0.571
2007 Levander S, Eberhard J, Lindström E. Nicotine use and its correlates in patients with psychosis. Acta Psychiatrica Scandinavica. Supplementum. 27-32. PMID 17953523 DOI: 10.1111/J.1600-0447.2007.01085.X  0.611
2007 Levander S, Eberhard J, Lindström E. Clinical decision-making during 5 years of antipsychotic treatment. Acta Psychiatrica Scandinavica. Supplementum. 17-26. PMID 17953522 DOI: 10.1111/J.1600-0447.2007.01084.X  0.611
2007 Lindström E, Eberhard J, Levander S. Five-year follow-up during antipsychotic treatment: efficacy, safety, functional and social outcome. Acta Psychiatrica Scandinavica. Supplementum. 5-16. PMID 17953521 DOI: 10.1111/J.1600-0447.2007.01083.X  0.64
2007 Neovius M, Eberhard J, Lindström E, Levander S. Weight development in patients treated with risperidone: a 5-year naturalistic study. Acta Psychiatrica Scandinavica. 115: 277-85. PMID 17355518 DOI: 10.1111/J.1600-0447.2006.00899.X  0.577
2007 Eberhard J, Lindström E, Holstad M, Levander S. Prolactin level during 5 years of risperidone treatment in patients with psychotic disorders. Acta Psychiatrica Scandinavica. 115: 268-76. PMID 17355517 DOI: 10.1111/J.1600-0447.2006.00897.X  0.622
2007 Tamminga C, Tanghoj P, Eberhard J. Identification of potential predictors of sertindole response in patients with schizophrenia European Psychiatry. 22: S141. DOI: 10.1016/J.Eurpsy.2007.01.453  0.407
2006 Eberhard J, Lindström E, Levander S. Tardive dyskinesia and antipsychotics: a 5-year longitudinal study of frequency, correlates and course. International Clinical Psychopharmacology. 21: 35-42. PMID 16317315 DOI: 10.1097/01.Yic.0000182120.51672.7D  0.637
2005 Lindström E, Farde L, Eberhard J, Haverkamp W. QTc interval prolongation and antipsychotic drug treatments: focus on sertindole. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 8: 615-29. PMID 15963244 DOI: 10.1017/S1461145705005250  0.374
2005 Lublin H, Eberhard J, Levander S. Current therapy issues and unmet clinical needs in the treatment of schizophrenia: a review of the new generation antipsychotics. International Clinical Psychopharmacology. 20: 183-98. PMID 15933479 DOI: 10.1097/00004850-200507000-00001  0.607
2003 Eberhard J, Riley F, Levander S. Premorbid IQ and schizophrenia. Increasing cognitive reduction by episodes. European Archives of Psychiatry and Clinical Neuroscience. 253: 84-8. PMID 12799746 DOI: 10.1007/S00406-003-0412-Y  0.606
Show low-probability matches.